A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.

More and more patients are developing type 2 diabetes while still young. The diagnosis may lead to a life of disease.

A study shows radiologists inconsistently identify AI-generated x-rays, highlighting emerging risks for clinical decision-making and data integrity.

The combined use of nirsevimab and maternal respiratory syncytial virus vaccine is linked to a lower burden of severe RSV infection among infants aged 7 months or younger in Washington state.

A cascade of beneficial effects hits the brain during exercise — with new data on strength training. Helping your patients ...

Ontario’s 2026 healthcare budget focuses on primary care and home care but doesn’t meet hospital care spending needs.

Greater weight loss during a 24-month primary care lifestyle intervention was associated with larger improvements in ...

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, ...

Infants with gastrointestinal manifestations suggestive of cow’s milk allergy may show growth deceleration in both weight and length.

Emerging evidence suggests nitrous oxide provides rapid relief for treatment-resistant depression. But is the therapy ready ...

Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...

Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was ...